Axogen, Inc. — Director's Dealing 2026

Feb 27, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2026-02-26

Reporting Person: Hartley Lindsey Marie (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-26	Common Stock	A	17453	—	Acquired	61906	Direct
2026-02-26	Common Stock	F	6630	$31.90	Disposed	55276	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-26	Restricted Stock Units	$	A	23000	Acquired		Common Stock (23000)	Direct

Footnotes

F1: This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria.

F2: This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent an open market sale.

F3: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F4: All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.